<code id='293AE31D38'></code><style id='293AE31D38'></style>
    • <acronym id='293AE31D38'></acronym>
      <center id='293AE31D38'><center id='293AE31D38'><tfoot id='293AE31D38'></tfoot></center><abbr id='293AE31D38'><dir id='293AE31D38'><tfoot id='293AE31D38'></tfoot><noframes id='293AE31D38'>

    • <optgroup id='293AE31D38'><strike id='293AE31D38'><sup id='293AE31D38'></sup></strike><code id='293AE31D38'></code></optgroup>
        1. <b id='293AE31D38'><label id='293AE31D38'><select id='293AE31D38'><dt id='293AE31D38'><span id='293AE31D38'></span></dt></select></label></b><u id='293AE31D38'></u>
          <i id='293AE31D38'><strike id='293AE31D38'><tt id='293AE31D38'><pre id='293AE31D38'></pre></tt></strike></i>

          explore

          explore

          author:leisure time    Page View:3155
          Illustration of a road with a chasm in the middle, indicating the end of a deal or a problem with a deal
          Adobe

          A deal is never really done until it’s done.

          On Tuesday, two different proposed insurance plan acquisitions on different sides of the country called it quits — one of them for the second time.

          advertisement

          California-based Medicare Advantage insurer SCAN Group has been trying to buy CareOregon, an insurer offering coverage to half a million people in Oregon’s state health plan, since January 2023. National insurer Elevance has also been trying to buy Blue Cross and Blue Shield of Louisiana since last January. The on-again, off-again purchase was paused in September 2023 because of state regulators’ concerns, but was resubmitted with a slightly different plan in December.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          Behind warning on Apellis’s eye drug lies a conflict of interest
          Behind warning on Apellis’s eye drug lies a conflict of interest

          MollyFerguson/STATTheeyediseasephysicianinchargeofacommitteethatflaggedararebutseveresideeffectinvol

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          Trader Joe's recalls 10K cases of broccoli cheddar soup over potential foreign material

          TraderJoe'srecalledover10,000casesofitsbroccolicheddarsoup.TraderJoe'sTraderJoe'shasissuedavolu